Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079799706> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W2079799706 endingPage "413" @default.
- W2079799706 startingPage "409" @default.
- W2079799706 abstract "Abstract: Gemtuzumab ozogamicin (GO) is a recently developed antibody‐targeted chemotherapeutic agent and has been expected to be less toxic than conventional chemotherapy. We retrospectively evaluated the use of GO in 38 patients. Patients with acute myeloid leukemia (AML) at diagnosis and relapsed AML were treated with 6 and 9 mg/m 2 GO. Efficacy and toxicity of GO were analyzed, as well as several prognostic factors. A complete response (CR) was observed in 12 of 38 patients, including five patients with CR plus incomplete regeneration of platelets. In one patient a partial remission was observed. Twenty‐five patients showed no change or progressive disease. The overall response (OR) in patients with AML at diagnosis was 47%, with the best response in patients with primary AML (OR 60%, compared with 21% OR in non‐primary AML, P = 0.045). The OR in patients with relapsed AML was 22%. Median white blood cell (WBC) before treatment, CD33 expression on leukemic blasts, and kinetics of response were analyzed as prognostic factors. Median WBC was significantly lower in patients who responded to GO, compared with non‐responders (2.1 × 10 9 /L vs. 6.8 × 10 9 /L, P = 0.036). CD33 expression and kinetics of response was not correlated to clinical outcome. Median days to reach 500 × 10 6 /L neutrophils and 100 × 10 9 /L platelets were 36 and 39 d, respectively. Infections and bleedings occurred in 45% and 12%, respectively. This report shows that GO has potent clinical activity and that the OR rate was by far the best in untreated primary AML patients." @default.
- W2079799706 created "2016-06-24" @default.
- W2079799706 creator A5032033167 @default.
- W2079799706 creator A5077101544 @default.
- W2079799706 creator A5080035300 @default.
- W2079799706 creator A5081186852 @default.
- W2079799706 date "2006-02-15" @default.
- W2079799706 modified "2023-10-12" @default.
- W2079799706 title "Efficacy and toxicity of gemtuzumab ozogamicin in patients with acute myeloid leukemia" @default.
- W2079799706 cites W1842764967 @default.
- W2079799706 cites W1972529152 @default.
- W2079799706 cites W1995322578 @default.
- W2079799706 cites W2013194808 @default.
- W2079799706 cites W2074426696 @default.
- W2079799706 cites W2081576971 @default.
- W2079799706 cites W2084486691 @default.
- W2079799706 cites W2138388661 @default.
- W2079799706 cites W2148047805 @default.
- W2079799706 cites W2764775166 @default.
- W2079799706 cites W3082443879 @default.
- W2079799706 cites W4211073672 @default.
- W2079799706 cites W4312790597 @default.
- W2079799706 cites W4385970358 @default.
- W2079799706 doi "https://doi.org/10.1111/j.1600-0609.2005.00623.x" @default.
- W2079799706 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16480432" @default.
- W2079799706 hasPublicationYear "2006" @default.
- W2079799706 type Work @default.
- W2079799706 sameAs 2079799706 @default.
- W2079799706 citedByCount "24" @default.
- W2079799706 countsByYear W20797997062012 @default.
- W2079799706 countsByYear W20797997062016 @default.
- W2079799706 countsByYear W20797997062018 @default.
- W2079799706 crossrefType "journal-article" @default.
- W2079799706 hasAuthorship W2079799706A5032033167 @default.
- W2079799706 hasAuthorship W2079799706A5077101544 @default.
- W2079799706 hasAuthorship W2079799706A5080035300 @default.
- W2079799706 hasAuthorship W2079799706A5081186852 @default.
- W2079799706 hasConcept C10205521 @default.
- W2079799706 hasConcept C126322002 @default.
- W2079799706 hasConcept C143998085 @default.
- W2079799706 hasConcept C176290653 @default.
- W2079799706 hasConcept C194409129 @default.
- W2079799706 hasConcept C2776694085 @default.
- W2079799706 hasConcept C2778461978 @default.
- W2079799706 hasConcept C2778488018 @default.
- W2079799706 hasConcept C2778623314 @default.
- W2079799706 hasConcept C2778729363 @default.
- W2079799706 hasConcept C2779282312 @default.
- W2079799706 hasConcept C28328180 @default.
- W2079799706 hasConcept C29730261 @default.
- W2079799706 hasConcept C54355233 @default.
- W2079799706 hasConcept C71924100 @default.
- W2079799706 hasConcept C86803240 @default.
- W2079799706 hasConcept C89560881 @default.
- W2079799706 hasConcept C90924648 @default.
- W2079799706 hasConceptScore W2079799706C10205521 @default.
- W2079799706 hasConceptScore W2079799706C126322002 @default.
- W2079799706 hasConceptScore W2079799706C143998085 @default.
- W2079799706 hasConceptScore W2079799706C176290653 @default.
- W2079799706 hasConceptScore W2079799706C194409129 @default.
- W2079799706 hasConceptScore W2079799706C2776694085 @default.
- W2079799706 hasConceptScore W2079799706C2778461978 @default.
- W2079799706 hasConceptScore W2079799706C2778488018 @default.
- W2079799706 hasConceptScore W2079799706C2778623314 @default.
- W2079799706 hasConceptScore W2079799706C2778729363 @default.
- W2079799706 hasConceptScore W2079799706C2779282312 @default.
- W2079799706 hasConceptScore W2079799706C28328180 @default.
- W2079799706 hasConceptScore W2079799706C29730261 @default.
- W2079799706 hasConceptScore W2079799706C54355233 @default.
- W2079799706 hasConceptScore W2079799706C71924100 @default.
- W2079799706 hasConceptScore W2079799706C86803240 @default.
- W2079799706 hasConceptScore W2079799706C89560881 @default.
- W2079799706 hasConceptScore W2079799706C90924648 @default.
- W2079799706 hasIssue "5" @default.
- W2079799706 hasLocation W20797997061 @default.
- W2079799706 hasLocation W20797997062 @default.
- W2079799706 hasOpenAccess W2079799706 @default.
- W2079799706 hasPrimaryLocation W20797997061 @default.
- W2079799706 hasRelatedWork W1964372198 @default.
- W2079799706 hasRelatedWork W2007433984 @default.
- W2079799706 hasRelatedWork W2018486897 @default.
- W2079799706 hasRelatedWork W2041164834 @default.
- W2079799706 hasRelatedWork W2090291749 @default.
- W2079799706 hasRelatedWork W2521706876 @default.
- W2079799706 hasRelatedWork W2554242132 @default.
- W2079799706 hasRelatedWork W2592079187 @default.
- W2079799706 hasRelatedWork W3047050124 @default.
- W2079799706 hasRelatedWork W4385825998 @default.
- W2079799706 hasVolume "76" @default.
- W2079799706 isParatext "false" @default.
- W2079799706 isRetracted "false" @default.
- W2079799706 magId "2079799706" @default.
- W2079799706 workType "article" @default.